June 6, 2018
Elections for the IDSA and HIVMA Board of Directors are quickly approaching.Read More
In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine.
Reviews: Opportunities for Antibiotic Optimization Exist Even Among the Most Vulnerable Patients; Single-Dose Fosfomycin for Uncomplicated Cystitis: Reason for Pause; Immunogenicity and Safety of Pneumococcal Conjugate Vaccine in Kidney Transplant Recipients
The Fiscal Year (FY) 2019 federal appropriations process is quickly moving forward.Read More
Following data indicating increased risks of neural tube defects among infants whose mothers became pregnant while taking dolutegravir-based regimens, the Department of Health and Human Services Antiretroviral Guidelines Panels on May 30 issued recommendations for treatment of adults and adolescents with HIV who are pregnant or of child-bearing potential.Read More
With representation at the 71st World Health Assembly, and reporting on an Ebola emergency panel’s findings, Science Speaks’ end of May coverage highlighted global health security events in Geneva...Read More